Stay updated on XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial
Sign up to get notified when there's something new on the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page.

Latest updates to the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing Revision: v3.2.0.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding operating-status notice at the top of the page has been removed.SummaryDifference0.4%

- Check42 days agoChange DetectedNo substantive changes to core study content were detected between the screenshots; all key elements (title, NCT number, sponsor, eligibility criteria, design, and outcomes) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference4%

- Check78 days agoChange DetectedAdded v3.1.0 and removed the Ovarian cancer resource; older v3.0.2 revision reference was present but superseded.SummaryDifference0.5%

- Check92 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element.SummaryDifference0.2%

Stay in the know with updates to XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page.